Curcumin-encapsulating Nanogels as an Effective Anticancer Formulation for Intracellular Uptake

Area of Science:

• Nanomedicine
• Materials Science
• Pharmacology

Background:

• Curcumin, a natural anticancer agent, suffers from poor solubility and bioavailability.
• Nanoscale drug delivery systems offer enhanced efficacy and safety for anticancer drugs.

Purpose of the Study:

• To develop and evaluate a novel colloidal nanogel carrier for curcumin encapsulation.
• To improve curcumin's solubility, bioavailability, and anticancer efficacy.

Main Methods:

• Formulation of an amphiphilic Poloxamer-cationic nanogel (NG127) encapsulating curcumin.
• Characterization of curcumin-nanogel complexes (C-NG) for size and drug content.
• Assessment of C-NG cellular uptake in MDA-231 breast cancer cells using multispectral imaging flow cytometry.
• Evaluation of C-NG's cytotoxicity and anti-proliferative effects on breast cancer cells using electronic sensing assays and fluorescent microscopy.

Main Results:

• Curcumin was efficiently encapsulated in NG127 nanogel carriers, forming homogenous complexes (ca. 150 nm) with 20-25% curcumin content.
• The curcumin-nanogel formulation (C-NG) showed enhanced cellular internalization into breast cancer cells.
• C-NG demonstrated significantly higher efficacy (70-85%) in inhibiting cancer cell growth compared to free curcumin at lower concentrations.
• The nanocarrier NG127 alone exhibited negligible cytotoxicity.

Conclusions:

• Novel nanogel carriers effectively encapsulate curcumin, enhancing its anticancer properties.
• This nanoformulation offers a promising strategy for more effective breast cancer therapeutics with reduced toxicity.
• The nanocarrier system holds potential for targeted drug delivery to tumors.